年龄相关性黄斑变性中的异常脂质代谢与补体激活
本文综述年龄相关性黄斑变性(AMD)中脂质代谢异常与补体系统失调的相互作用,强调异常脂质谱(如高密度脂蛋白水平改变、氧化脂质沉积、细胞内脂褐素积聚)可加剧补体激活并放大组织损伤。遗传学研究显示AMD与脂质转运及补体调节相关基因显著关联。作者提出将脂质代谢调节剂与补体抑制剂联合的双靶点治疗策略。
要点
- 脂质代谢异常与补体失调通过慢性炎症、玻璃膜疣形成和视网膜色素上皮功能障碍促进AMD进展。
- 异常脂质谱(高密度脂蛋白改变、氧化脂质沉积、脂褐素积聚)可加剧补体激活并放大组织损伤。
- 遗传学研究显示AMD与脂质转运和补体调节相关基因存在显著关联。
核心结论
- 脂质代谢异常与补体激活的相互作用在AMD发病机制中起关键作用,整合脂质代谢调节剂与补体抑制剂的双靶点方法有望改善AMD患者结局。
研究设计与样本
- 综述,总结近期关于脂质代谢与补体系统相互作用在AMD中研究进展。
主要发现
- 异常脂质谱,尤其高密度脂蛋白水平改变、氧化脂质沉积和细胞内脂褐素积聚,作为加剧因素增强补体激活并放大AMD组织损伤。
- 遗传学研究揭示AMD与参与脂质转运和补体调节的特定基因存在显著关联。
- 脂质代谢异常和补体系统失调通过慢性炎症、玻璃膜疣形成和视网膜色素上皮功能障碍促进AMD进展。
临床怎么用
- 作者主张采用整合脂质代谢调节剂与补体抑制剂的双靶点治疗新方法,认为同时靶向这两条通路有望显著改善AMD患者结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Age-related macular degeneration (AMD) stands as a leading cause of severe visual impairment and blindness among the elderly globally. As a multifactorial disease, AMD's pathogenesis is influenced by genetic, environmental, and age-related factors, with lipid metabolism abnormalities and complement system dysregulation playing critical roles. This review delves into recent advancements in understanding the intricate interaction between these two crucial pathways, highlighting their contribution to the disease's progression through chronic inflammation, drusen formation, and retinal pigment epithelium dysfunction. Importantly, emerging evidence points to dysregulated lipid profiles, particularly alterations in high-density lipoprotein levels, oxidized lipid deposits, and intracellular lipofuscin accumulation, as exacerbating factors that enhance complement activation and subsequently amplify tissue damage in AMD. Furthermore, genetic studies have revealed significant associations between AMD and specific genes involved in lipid transport and complement regulation, shedding light on disease susceptibility and underlying mechanisms. The review further explores the clinical implications of these findings, advocating for a novel therapeutic approach that integrates lipid metabolism modulators with complement inhibitors. By concurrently targeting these pathways, the dual-targeted approach holds promise in significantly improving outcomes for AMD patients, heralding a new horizon in AMD management and treatment.
引用
- Tang S, Yang J, Xiao B, et al. Aberrant Lipid Metabolism and Complement Activation in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2024. PMID: 39405051. doi:10.1167/iovs.65.12.20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。